📗 Cite This Artifact
SNX5 (Sorting Nexin 5)
<div class="infobox infobo-gene">
<table>
<tr><th>Gene Symbol</th><td>SNX5</td></tr>
<tr><th>Full Name</th><td>Sorting Nexin 5</td></tr>
<tr><th>Chromosomal Location</th><td>16p13.3</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/11157" target="_blank">11157</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/605799" target="_blank">605799</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000189007</td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprot/Q9UPN3" target="_blank">Q9UPN3</a></td></tr>
<tr><th>Protein Family</th><td>SNX-BAR (Sorting Nexin-Bin/Amphiphysin/Rvs)</td></tr>
<tr><th>Expression</th><td>Brain, Heart, Muscle, Kidney</td></tr>
</table>
</div>
Overview
Sorting Nexin 5 (SNX5) is a member of the SNX-BAR (Sorting Nexin-Bin/Amphiphysin/Rvs) subfamily of sorting nexin proteins that play critical roles in intracellular membrane trafficking. SNX5 contains a PX domain (phox homology) that specifically binds to phosphoinositides, particularly phosphatidylinositol-3-phosphate (PI3P), which is enriched on early endosomes[@cullen2024]. The protein also possesses a BAR domain that enables it to induce membrane curvature and facilitate vesicle formation.
<div class="infobox infobo-gene">
<table>
<tr><th>Gene Symbol</th><td>SNX5</td></tr>
<tr><th>Full Name</th><td>Sorting Nexin 5</td></tr>
<tr><th>Chromosomal Location</th><td>16p13.3</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/11157" target="_blank">11157</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/605799" target="_blank">605799</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000189007</td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprot/Q9UPN3" target="_blank">Q9UPN3</a></td></tr>
<tr><th>Protein Family</th><td>SNX-BAR (Sorting Nexin-Bin/Amphiphysin/Rvs)</td></tr>
<tr><th>Expression</th><td>Brain, Heart, Muscle, Kidney</td></tr>
</table>
</div>
Overview
Sorting Nexin 5 (SNX5) is a member of the SNX-BAR (Sorting Nexin-Bin/Amphiphysin/Rvs) subfamily of sorting nexin proteins that play critical roles in intracellular membrane trafficking. SNX5 contains a PX domain (phox homology) that specifically binds to phosphoinositides, particularly phosphatidylinositol-3-phosphate (PI3P), which is enriched on early endosomes[@cullen2024]. The protein also possesses a BAR domain that enables it to induce membrane curvature and facilitate vesicle formation.
SNX5 functions as a key component of the retromer complex, participating in cargo sorting and retrograde transport from endosomes to the trans-Golgi network (TGN)[@carlton2024]. Additionally, SNX5 plays important roles in autophagy regulation by mediating autophagosome-lysosome fusion[@cheng2024]. Through these mechanisms, SNX5 has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease), where endosomal/lysosomal dysfunction is a hallmark pathology[@nalls2023][@tan2023].
Structure and Function
Domain Architecture
SNX5 is a 406-amino acid protein with a multi-domain architecture:
N-terminus C-terminus
│ │
┌────┴────┐ ┌────┴────┐
│ │ │ │
│ PX Domain │══════════════════════════════════| BAR Domain │
│ (1-120 aa) │ Flexible Linker │ (250-380 aa) │
│ │ │ │
│ PI3P binding│ │ Membrane │
│ Membrane │ │ curvature │
│ recruitment │ │ SNX5 dimer │
└─────────────┘ └──────────────┘
PX Domain (Residues 1-120)
- Phosphoinositide binding: Specifically recognizes PI3P on early endosomes
- Membrane targeting: Directs SNX5 to endosomal membranes
- Protein interactions: Mediates binding to retromer complex and other partners
BAR Domain (Residues 250-380)
- Membrane deformation: Induces curvature of endosomal membranes
- Dimerization: Forms SNX5 homodimers for function
- Cargo recognition: Participates in cargo selection
- SNX-BAR network: Works with other SNX-BAR proteins (SNX1, SNX2, SNX6)
Structural Insights
The BAR domain forms a curved dimeric structure that aligns with the convex surface of curved membranes. This enables:
- Tubulation: Formation of tubular protrusions from endosomes
- Cargo capture: Recognition of transmembrane cargo proteins
- Sorting: Segregation of cargo into retrieval or degradation pathways
Mutations in the BAR domain can disrupt SNX5 function and are linked to neurological disorders.
Biological Functions
Endosomal Sorting and Retromer Function
SNX5 plays a central role in endosomal sorting through its interaction with the retromer complex:
Retromer Complex
The retromer is a heterotrimeric complex consisting of:
- VPS26: Cargo recognition subunit (VPS26A/VPS26B)
- VPS29: Scaffold protein
- VPS35: Core scaffolding subunit
SNX5 interacts with the retromer through multiple mechanisms:
- Direct binding to VPS35
- Cooperation with FAM21 (actin regulator)
- Assembly into SNX5-SNX6 heterodimers
Cargo Selection
SNX5 participates in sorting of numerous cargo proteins:
| Cargo | Destination | Pathway |
|-------|-------------|---------|
| CI-MPR | TGN | Retrieval |
| Sortilin | TGN | Retrieval |
| WNTless | TGN | Secretory |
| APP | TGN | Processing |
| LRP1 | TGN | Signaling |
Autophagy Regulation
SNX5 is critically involved in autophagy through multiple mechanisms:
Autophagosome Formation
- Pre-autophagosomal structure (PAS): SNX5 localizes to nascent autophagosomes
- Membrane recruitment: Facilitates membrane acquisition for autophagosomes
- Atg5-Atg12 complex: Interacts with early autophagy machinery
Autophagosome-Lysosome Fusion
- Tethering function: SNX5 acts as a tether between autophagosomes and lysosomes
- SNARE complex: Coordinates with syntaxin17 (STX17) and VAMP8
- HOPS complex: Works with homotypic fusion and vacuole protein sorting (HOPS) tethering complex
Selective Autophagy
- Pexophagy: SNX5 mediates peroxisome degradation
- Mitophagy: Role in mitochondrial quality control
- Aggrephagy: Clearance of protein aggregates (critical for neurodegeneration)
Receptor Signaling Modulation
SNX5 regulates multiple receptor signaling pathways:
EGFR Signaling
- Endocytic trafficking: Modulates EGFR internalization and degradation
- Signal termination: Controls duration of growth factor signaling
- Spatial regulation: Directs EGFR to specific cellular compartments[@zhu2023]
GPCR Signaling
- GPCR endocytosis: Regulates G protein-coupled receptor trafficking
- Receptor recycling: Controls return of receptors to the plasma membrane
- Signal desensitization: Facilitates receptor downregulation
Integrin Signaling
- Adhesion turnover: Modulates integrin dynamics at cell-matrix contacts
- Migration: Affects cell migration and invasion capabilities
Expression Pattern
Tissue Distribution
| Tissue | Expression Level | Notes |
|--------|-----------------|-------|
| Brain | Very High | Cerebral cortex, hippocampus, cerebellum |
| Heart | High | Cardiac muscle |
| Skeletal Muscle | High | Skeletal myocytes |
| Kidney | High | Renal tubules |
| Liver | Medium | Hepatocytes |
| Lung | Medium | Alveolar cells |
Brain Expression
Within the brain, SNX5 shows specific cellular and regional patterns:
Cellular Localization
- Neurons: High expression in pyramidal neurons, Purkinje cells
- Astrocytes: Moderate expression in astrocytic processes
- Microglia: Low-basal, increases in activation state
Regional Distribution
- Cerebral cortex: Highest in layer 5 pyramidal neurons
- Hippocampus: CA1-CA3 pyramidal cells, dentate gyrus granule cells
- Cerebellum: Purkinje cell layer
- Basal ganglia: Striatal medium spiny neurons
- Substantia nigra: Dopaminergic neurons
Recent single-cell studies have characterized SNX5 expression across brain cell types[@zhang2024], revealing:
- Neuronal enrichment in most brain regions
- Specific patterns in glia during injury/disease
- Developmental regulation of expression
Disease Associations
Parkinson's Disease
SNX5 has been implicated in [Parkinson's disease](/diseases/parkinsons-disease) through multiple lines of evidence:
Genetic Evidence
- GWAS: SNX5 is located in a chromosomal region linked to sporadic PD risk[@nalls2023]
- Expression studies: Altered SNX5 expression in PD brains
- eQTLs: Expression quantitative trait loci connect SNX5 to PD risk
Pathogenic Mechanisms
- SNX5 regulates endosomal trafficking of [α-synuclein](/proteins/alpha-synuclein)
- Dysfunction leads to impaired clearance of toxic species
- Contributes to Lewy body formation
- SNX5 is essential for proper lysosomal function in dopaminergic neurons
- Impaired autophagy leads to accumulation of toxic proteins
- Affects neuronal survival in the substantia nigra
- SNX5 participates in endosomal sorting of [LRRK2](/genes/lrrk2)
- Dysregulated LRK2 trafficking contributes to pathogenesis
- Interaction with G2019S mutant LRRK2
Therapeutic Implications
- Enhancing autophagy: SNX5 activators could improve protein clearance
- Endosomal function: Modulators might restore proper trafficking
- Combination approaches: Target multiple trafficking pathways
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease), SNX5 plays important roles in amyloid processing and neuronal health:
Amyloid Precursor Protein (APP) Trafficking
- APP processing: SNX5 regulates [APP](/entities/app-protein) trafficking through the endosomal system
- Aβ production: Altered SNX5 affects amyloidogenic processing by [BACE1](/entities/bace1)
- Secretion: Controls release of Aβ peptides
Synaptic Function
- Synaptic trafficking: SNX5 localizes to synaptic regions
- Receptor recycling: Regulates glutamate receptor trafficking
- Synaptic plasticity: Affects learning and memory mechanisms
Expression Changes
- Reduced SNX5: Levels decreased in AD cortex[@tan2023]
- Regional specificity: Particularly affected in frontal and temporal cortices
- Cellular patterns: Loss in vulnerable neuronal populations
Neuropathology
- Tau pathology: Connection to tau-mediated neurodegeneration
- Endosomal dysfunction: Early marker of AD progression
- Biomarker potential: SNX5 as a therapeutic target
Other Neurodegenerative Disorders
Huntington's Disease
- Mutant huntingtin: SNX5 affected by toxic polyglutamine expansions
- Vesicle trafficking: Disrupted in HD models
- Therapeutic target: Modulation may protect neurons
Amyotrophic Lateral Sclerosis (ALS)
- Endosomal dysfunction: Common pathway in ALS pathogenesis
- Protein aggregates: SNX5 in autophagic clearance
- Motor neuron vulnerability: Specific effects on motor neurons
Multiple System Atrophy (MSA)
- Oligodendroglial dysfunction: SNX5 in myelinating cells
- Myelin formation: Affected in MSA pathology
- α-Synuclein: Interaction with glial pathology
Therapeutic Targeting
Rationale
SNX5 represents a compelling therapeutic target for neurodegenerative diseases due to:
Drug Development Strategies
| Approach | Mechanism | Status | Notes |
|----------|-----------|--------|-------|
| Small molecule activators | Enhance SNX5 function | Preclinical | Increase autophagy flux |
| Peptide mimetics | Promote SNX5-retromer binding | Research | Improve cargo sorting |
| Gene therapy | Increase SNX5 expression | Preclinical | AAV delivery |
| ASO/RNAi | Reduce pathological function | Research | For gain-of-function |
Challenges
Preclinical Models
Cell Culture
- Neuronal models: iPSC-derived neurons
- Glial models: Astrocytes, microglia
- Organoids: Brain organoids for disease modeling
Animal Models
- Transgenic mice: SNX5 overexpression/knockout
- AAV models: Viral delivery to CNS
- Phenotypic readouts: Behavioral, biochemical, histological
Interactome
Protein-Protein Interactions
| Partner | Interaction Type | Function |
|---------|-----------------|----------|
| Retromer (VPS35) | Direct binding | Cargo sorting |
| SNX1 | Heterodimer | SNX-BAR complex |
| SNX6 | Heterodimer | SNX-BAR complex |
| FAM21 | Direct binding | Actin regulation |
| PI3P | Lipid binding | Membrane localization |
| STX17 | Tethering | Autophagosome-lysosome fusion |
| VAMP8 | SNARE complex | Fusion machinery |
Signaling Pathways
Brain Atlas Resources
- [Allen Human Brain Atlas - SNX5 Expression](https://human.brain-map.org/microarray/search/show?search_term=SNX5): Gene expression across cortical regions
- [Allen Mouse Brain Atlas - SNX5](https://mouse.brain-map.org/search?type=gene&term=SNX5): Mouse brain expression patterns
- [Allen Cell Type Atlas](https://celltype.brain-map.org/): Single-cell expression data
See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [VPS35](/genes/vps35) - Retromer complex subunit
- [SNX1](/entities/snx1) - Sorting Nexin 1
- [SNX2](/entities/snx2) - Sorting Nexin 2
- [Endosomal Trafficking](/mechanisms/endosomal-lysosomal-pathway)
- [Autophagy in Neurodegeneration](/mechanisms/autophagy-lysosomal-pathway)
- [Retromer Complex](/mechanisms/retromer-pathway)
- [Alpha-Synuclein](/proteins/alpha-synuclein)
- [APP Processing](/mechanisms/app-processing-pathway)
External Links
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/11157](https://www.ncbi.nlm.nih.gov/gene/11157)
- UniProt: [https://www.uniprot.org/uniprot/Q9UPN3](https://www.uniprot.org/uniprot/Q9UPN3)
- Ensembl: [https://www.ensembl.org/Homo_sapiens/ENSG00000189007](https://www.ensembl.org/Homo_sapiens/ENSG00000189007)
- OMIM: [https://www.omim.org/entry/605799](https://www.omim.org/entry/605799)
- UCSC Genome Browser: [SNX5 locus](https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg38&position=chr16%3A16200000-16500000)
- [Allen Human Brain Atlas](https://brain-map.org/)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | entities-snx5 |
| kg_node_id | None |
| entity_type | entity |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-df98fedb7f4a |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'entities-snx5'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-entities-snx5?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[SNX5 (Sorting Nexin 5)](http://scidex.ai/artifact/wiki-entities-snx5)
http://scidex.ai/artifact/wiki-entities-snx5